Search results
For people with early-stage liver cancers who have a liver transplant, the 5-year survival rate is in the range of 60% to 70%. Understanding the numbers. People now being diagnosed with liver cancer may have a better outlook than these numbers show.
- Signs and Symptoms of Liver Cancer
Having one or more of the symptoms below does not mean you...
- Questions to Ask About Liver Cancer
Our 24/7 cancer helpline provides information and answers...
- Can Liver Cancer Be Found Early
In some studies, screening was linked to improved survival...
- Tests for Liver Cancer
But liver cancer isn’t the only reason for high AFP levels....
- Liver Cancer Stages
Other liver cancer staging systems. The staging systems for...
- Immunotherapy for Liver Cancer
Atezolizumab can be used along with the targeted drug...
- What's New in Liver Cancer Research
Several new blood tests are being studied to see if they can...
- Radiation Therapy for Liver Cancer
Although liver cancer cells are sensitive to radiation, much...
- Signs and Symptoms of Liver Cancer
21 sty 2021 · Long-term outcomes of liver transplantation are considered superior than resection, which has a 70% recurrence rate and a 10-year survival of 7–15% 188. However, transplantation is plagued by...
Primary liver cancer remains the fourth-leading cause of cancer-related death worldwide (1, 2). Most primary liver cancers (>80%) are hepatocellular carcinoma (HCC), with intrahepatic cholangiocarcinoma (iCCA) being the second-most common and accounting for 10%-15% (2).
16 sie 2023 · The relative five-year survival rate for liver cancer is 19.6%, but that rate can differ by stage. When that is broken down into stages, the number can change drastically. This is because when liver cancer is caught early, the survival outlook is much higher than if it is caught in its latest stages.
We predicted the future number of primary liver cancer cases and deaths up to the year 2040 based on the medium-variant UN population projections and the current global-level incidence and mortality rates of primary liver cancer for 2020.
28 cze 2023 · Results. From 1990 to 2019, the ASDR of liver cancer decreased globally (EAPC = − 2.23, 95% confidence interval [CI]: − 2.61 to − 1.84). Meanwhile, declining trends were observed in both sexes, socio-demographic index (SDI) areas, and geographies, particularly East Asia (EAPC = − 4.98, 95% CI: − 5.73 to − 4.22).
6 wrz 2022 · In 2020, almost 906 000 people were diagnosed with liver cancer globally, the most common form of which was hepatocellular carcinoma (figure 1). 1 Hepatocellular carcinoma is the third leading cause of cancer deaths worldwide, with a relative 5-year survival rate of approximately 18%.